ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices

Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices

INTRODUCTION — As technology advances, medical devices are more frequently relying upon software incorporating artificial intelligence (AI). Specifically, machine-learning is generating real world evidence from the delivery of health care, which in turn is becoming integrated into emerging medical devices.

However, regulatory approval and oversight of these devices is necessary. The US Food and Drug Administration (FDA) has granted regulatory approval to a number of machine learning-enabled medical devices and has published them in a publicly available list [1]. These devices are included in the sections below, including a description of each device excerpted and edited from the FDA approval documentation. Additional sources have also been referenced in creation of this list of FDA approved devices [2].

Critically, inclusion of a given device on this list does not indicate UpToDate endorsement of its use. Please refer to UpToDate content on relevant clinical issues for information on the UpToDate approach to diagnosis, monitoring, and management.

CARDIOLOGY

Arrhythmias

DeepRhythmAI – The DeepRhythmAI (DRAI) software is used to detect arrhythmias and automatically analyze electrocardiograms (ECG) [3]. DRAI is a cloud-based AI algorithm that analyzes all the heart beats in the processed ECG signal and based on that classifies them as either correct or arrhythmic.

Verily Study Watch with irregular pulse monitor – The Study Watch is a miniature wearable device that continuously monitors the ECG and heart rate, among other data [4,5].

Zeus system Zio watch – The Zio Watch Service is used in adults with atrial fibrillation (AF) or susceptibility to AF to analyze the ECG and photoplethysmogram, in order to detect AF [6].

Apple Watch atrial fibrillation history feature – The AFib History Feature analyzes pulse rate data from the Apple watch to identify irregular heart rhythms suggestive of AF, and provides an estimate of the time spent in AF [7,8]. It includes a medical app on the Apple Watch as well as one on the iPhone.

Apple IRNF app – The Irregular Rhythm Notification Feature is a medical application that analyzes pulse rate data from the Apple Watch and notifies the wearer if AF is present [9,10].

AliveCor KardiaMobile 6L and AliveCor QT KardiaMobile 6L is a device to obtain an ECG, which clinicians can use to manually measure their patients' QT interval [11,12]. AliveCor QT Service is cloud-based software that provides clinicians with the heart-rate corrected QT.

Implicity IM007 – IM007 records and analyzes ECG data from Insertable Cardiac Monitors (ICM) to help diagnose arrhythmias [13].

LINQ II Insertable Cardiac Monitor, Zelda AI ECG Classification System – The LINQ II ICM is an insertable device that records ECG [14,15]. It can be activated by the patient or can be automatically activated. It is used in adults with risk for or symptoms of arrhythmias.

Zio ECG Utilization Software and AT ECG Monitoring System, Zeus System – The Zio ECG Utilization Software and AT ECG Monitoring System process ECG data from compatible monitoring devices, allowing for detection of arrhythmias (either automatically or via analysis of patient triggered events) [16-19]. After data collection, a report is generated for clinician review. These devices are used in patients at risk for or with symptoms of an arrhythmia.

VX1 – The VX1 is a machine learning software that helps providers identify intracardiac atrial electrograms exhibiting spatiotemporal dispersion during an ablation procedure for AF [20,21].

RX-1 Rhythm Express Remote Cardiac Monitoring System – The Rhythm Express is a remote cardiac monitoring system [22]. The device connects to standard ECG electrodes to capture two channel ECGs. An embedded algorithm processes the acquired ECG to detect arrhythmias, compress the ECG, and remove most in-band noise without distorting the electrocardiogram. It can function in one of three modes: mobile cardiac telemetry, event recorder, and wireless Holter, and can be worn by patients for up to two weeks.

BodyGuardian Remote Monitoring System – The BodyGuardian System detects and monitors cardiac arrhythmias in ambulatory patients [23]. The device makes use of commercially-available, external plug-in devices such as ECG sensors, blood pressure meters, and pulse oximeters.

AI-ECG Tracker – The AI-ECG Tracker uses machine learning to assess ambulatory ECG data to identify arrhythmias in adults without pacemakers [24]. The interpretations by the analysis program can be confirmed, edited, modified, or deleted by qualified clinicians.

AI-ECG Platform – The AI-ECG Platform uses machine learning to assist clinicians in the interpretation of a 12-lead resting ECG. The interpretation by the analysis program may then be confirmed, edited, or deleted by qualified clinicians [25].

Eko Analysis Software – The Eko Analysis Software assists in the evaluation of patients' heart sounds and ECG [26]. The software detects suspected murmurs as well as AF and normal sinus rhythm. It can also calculate heart rate, QRS duration, and electromechanical activation time. It does not identify arrhythmias other than AF and does not identify the type of murmur.

PhysIQ Heart Rhythm and Respiratory Module – The physIQ Heart Rhythm and Respiration Module is used to calculate heart rate and heart rate variability, to detect AF, and to determine respiration rate by automated analysis of ambulatory ECG data and triaxial accelerometers [27,28].

Loop System – The Loop System records arterial oxygen saturation, heart rate, and respiratory rate in adult patients in the home environment. This data is subsequently transmitted to a web server for remote review by a clinician [29,30].

KardiaAI – KardiaAI is a software analysis library that assists in the assessment of ECG rhythms (eg, normal sinus rhythm, AF, bradycardia, and tachycardia) in ambulatory electrocardiograms recorded from a variety of devices including event recorders [31,32].

RhythmAnalytics – RhythmAnalytics is a software that assesses for cardiac arrhythmias using single-lead ECG data; clinicians should review and confirm the analytic result [33].

Rx-1 Rhythm Express Remote Cardiac Monitoring System – The Rhythm Express remote cardiac monitoring system provides continuous monitoring of ECG, functioning in one of three modes: mobile cardiac telemetry, event recorder, and wireless Holter [34].

Cardio-TriTest v6.5 – The Cardio-TriTest v6.5 combines the results from a 12-lead ECG, a 4-lead phonocardiograph, and a 4-lead mechanocardiograph into a contiguous presentation that aids in diagnostic interpretation by a clinician [35].

FibriCheck – FibriCheck can be used by patients to self-monitor for AF on an intermittent basis [36].

Rooti Rx ECG Event Recorder, Rooti Link APP Software – Rooti Rx System allows an outpatient to record a single-lead ECG for review by their health care provider [37,38].

Peerbridge Cor(TM) System – The Peerbridge Cor System is a wearable monitoring device that captures and transmits symptomatic events and continuous ECG data for 24 hours and up to seven days and provides the data to the clinician for review [39].

CardioLogs ECG Analysis Platform – The CardioLogs ECG Analysis Platform analyzes data that is recorded from compatible devices used for the arrhythmia diagnostics (eg, Holter, event recorder) [40,41]. It can be electronically interfaced and perform analysis with data transferred from other computer-based ECG systems.

Reveal LINQ – A Reveal LINQ insertable cardiac monitor is a small device placed under the skin that continuously monitors heart rhythm for up to three years [42-44].

FEops HEARTguide – FEops HEARTguide performs computer simulation of transcatheter left atrial appendage occlusion (LAAO) device implantation during procedural planning [45-48]. It predicts implant frame deformation to guide LAAO device size and placement.

Hemodynamics (vital signs monitoring)

Gili Pro Biosensor (also known as Gili Biosensor System) – The Gili Pro BioSensor includes an optical module that captures motion-vibration signals from an illuminated surface to collect data such as heart and respiratory rate [49,50].

Oxehealth Vital Signs – The Oxehealth Vital Signs device is software that analyzes video footage to estimate a subject's heart and respiratory rate when the patient is stationary [51,52]. It is indicated for use in a hospital room, or in other secured environments that require a trained professional to perform periodic checks on a patient. It is not appropriate for the critical care setting or in those needing continuous vital sign monitoring.

Analytic for Hemodynamic Instability (AHI) – The AHI software is used in adults receiving continuous ECG monitoring [53,54]. AHI uses the ECG to characterize the patient's hemodynamic status and identify signs of hemodynamic instability.

CLEWICU System (ClewICUserver and ClewICUnitor) – CLEWICU is used in the intensive care unit (ICU) to predict a patient's likelihood of future hemodynamic instability [55-58].

PeraMobile, PeraWatch, PeraServer, PeraTrend – These devices are used to track, monitor, and display the Rothman Index (RI) within a hospital setting. The RI uses aggregates vital signs, laboratory values, and nursing assessments to produce a single score that reflects the patient's mortality risk [59,60].

Biovitals Analytics (BA) Engine – The BA Engine is used with continuous health data collected from sensors that monitor heart rate, respiratory rate, and activity in ambulatory patients either in a health care facility or at home, during times of minimal activity [61,62]. The device calculates a time series Biovitals Index (BI), which is a reflection of the difference between a patient's measured vital signs and their previous baseline values.

Edwards Lifesciences Acumen Hypotension Prediction Index and Software – The Edwards Lifesciences Acumen Hypotension Prediction Index feature provides the probability that a patient will have a future hypotensive event [63,64]. It is used in patients receiving advanced hemodynamic monitoring, in conjunction with other clinical information. The device consists of software paired with an extravascular blood pressure transducer and a radial arterial catheter. It is used in patients receiving advanced hemodynamic monitoring, in conjunction with other clinical information.

WAVE Clinical Platform – The WAVE Clinical Platform is software that manages and displays information from multiple sources including medical devices, Electronic Medical Records, and Clinical Information Systems [65]. It is a remote monitoring platform that displays physiologic data, waveforms, alarms, results, and diagnostic information routed through the WAVE Clinical Platform from supported devices and systems. The WAVE Clinical Platform is intended for use in hospital or hospital-type environments.

Tyto Stethoscope – The Tyto Stethoscope is an electronic stethoscope that allows for a clinician in one location to hear the auscultation sounds of a patient on site or at a different location on the IP network [66,67]. It allows four types of exams: heart, lungs, heart rate, and audio.

Personalized Physiology Analytics Engine Software – The PhysIQ Personalized Physiology Analytics Engine ("PPA Engine") is a computerized analysis software program that is designed for detecting change in the relationships among the patient's vital signs throughout dynamic physical activity [68], based on data input from multi-parameter vital sign monitoring devices.

Visensia – Visensia with alert is a software accessary to patient monitors (bedside or ambulatory) and clinical information systems and is used in adult patients in whom multiparameter patient monitoring is needed [69,70].

Heart sounds

Eko Murmur Analysis Software (EMAS) – EMAS allows users to upload phonocardiograms and ECG signals and provides the clinician with an analysis and decision support regarding the patient's heart sounds [71].

eMurmur Heart AI – The 'eMurmur Heart AI' software provides an automated analysis of recorded heart sounds from a digital stethoscope and identifies S1, S2, physiologic heart murmurs, pathologic heart murmurs, and the absence of a heart murmur [72,73].

eMurmur ID – The eMurmur ID software system records, displays, and analyzes heart sounds recorded by an electronic stethoscope, and identifies S1, S2, physiologic heart murmurs, pathologic heart murmurs and absence of a heart murmur [74].

Stethee Pro 1, Stethee Pro Software System – The Stethee Pro 1 is an electronic stethoscope that is used to detect, record, and amplify sounds from the heart, lungs, arteries, veins, and other internal organs [75]. With the Stethee Pro Software System data can be analyzed and shared with other authorized users.

Steth IO – The StratoScientific Steth IO Stethoscope and Phonocardiogram Model 1.0 is used to detect and amplify sounds from the heart and lungs with the use of selective frequency ranges [76].

Coronary artery disease

DEEPVESSEL FFR (DVFFR) – DEEPVESSEL FFR is simulation software that provides an analysis of separately-acquired Computed Tomography Digital Imaging and Communications in Medicine (CT DICOM) data in patients with symptomatic but clinically stable coronary artery disease (CAD) [77,78].

HeartFlow Analysis – The HeartFlow Analysis is simulation software that provides analysis of CT DICOM data to assess the anatomy and function of the coronary arteries [56-58].

FFRangio – CathWorks FFRangio is a software that provides analysis of separately-acquired angiography DICOM data for patients with CAD [79-81]. FFRangio analysis assesses coronary artery anatomy and function, and supports the evaluation of CAD. It retrieves standard angiographic images on which the user selects and marks the target lesion, ostium location, main vessel, target vessel, and other key features.

HeartfFow FFRCT Analysis – HeartFlow Analysis is simulation software that analyzes separately-acquired CT DICOM data for symptomatic but clinically stable patients with CAD [56-58,82]. FFRCT analysis assess coronary artery anatomy and function, thereby supporting the evaluation of CAD. There is also a version 2.0 [83].

Heart failure

SOZO – The SOZO Fluid Status Monitor provides noninvasive monitoring of patients heart failure and fluid management problems to assist their clinician in management [84,85].

ENDOCRINOLOGY

Diabetes

DreaMed Advisor Pro – DreaMed Advisor Pro is software that provides recommendations for the adjustment of insulin for patients who have type 1 diabetes and are using an insulin pump and continuous glucose monitoring [86].

One Drop Blood Glucose Monitoring System – The One Drop Blood Glucose Monitoring System measures blood glucose levels from blood samples drawn from the fingertip [87].

Dario Blood Glucose Monitoring System – The Dario Blood Glucose Monitoring System measures blood glucose levels [88]. The Dario App displays the results in real time and also provides alerts and reminders.

WellDoc BlueStar – The WellDoc BlueStar System securely captures and transmits blood glucose data to assist patients and their health care providers in diabetes management [89,90]. It also provides motivational and educational coaching messages based on blood glucose values and trends to promote medication adherence.

D-Nav System – The d-Nav System is a software-based, prescription-only product designed to provide the next insulin dose recommendation as an aid for personal insulin management [91,92].

EndoTool SubQ – EndoTool SubQ is software that makes recommendations to the health care provider regarding an individual patient's next dose of subcutaneous insulin [93].

GASTROENTEROLOGY

Colonic polyps

EndoScreener – The EndoScreener uses input from the colonoscopy video and provides computer-assisted detection of colorectal polyps in real time [94].

GI Genius – The GI Genius System is used in patients undergoing white-light endoscopy and provides computer-assisted detection of colonic mucosal lesions (eg, polyps and adenomas) in real time [95].

Other endoscopic findings

NvisionVLE Imaging System, NvisionVLE Optical Probe, NvisionVLE Inflation System – The NvisionVLE Imaging System evaluates and provides an image of tissue microstructure, using two-dimensional, cross-sectional, and real-time depth visualization [96].

GENETICS

23andMe Personal Genome Service (PGS) Genetic Health Risk Test – The 23andMe PGS Test uses qualitative genotyping to detect variants in the DNA that suggest health risks for specific conditions [97]. These include:

Hereditary thrombophilia

Alpha-1 antitrypsin deficiency

Late-onset Alzheimer's Disease

Parkinson's Disease

Gaucher Disease Type 1

Factor XI deficiency

Celiac disease

Glucose-6-phosphate-dehydrogenase deficiency

Hereditary hemochromatosis

Early-onset primary dystonia

NEPHROLOGY

Urinalysis

Minuteful - kidney test – The Minuteful - kidney test is a kit and smartphone application that measures and displays albumin and creatinine in urine, along with the albumin-creatinine ratio [98].

ACR | LAB Urine Analysis Test System – The ACR | LAB Urine Analysis Test System is a kit (including a color board and reagent strips) along with a smartphone application that measures albumin and creatinine in urine and displays the results, along with the albumin-creatinine ratio [99].

DIP/U.S. Urine Analysis Test System – The DIP/U.S. Urine Analysis Test System is a kit (including a color board and reagent strips) along with a smartphone application that measures urine parameters including pH, glucose, protein, specific gravity, blood, and nitrate and provides these results directly to the clinician to aid in the diagnosis and monitoring of kidney disease [100].

NEUROLOGY

Traumatic brain injury and concussion

BrainScope TBI – BrainScope TBI is a portable device that provides a multiparameter assessment based on the patient's electroencephalogram, cognitive exam, and clinical symptoms in order to aid in the diagnosis of concussion (mild traumatic brain injury) [101].

EyeBOX – The EyeBOX analyzes eye movements as an aid in the diagnosis of concussion in conjunction with a standard neurologic assessment [102,103].

Upper limb prosthetics

Myo Plus – Myo Plus is used as the control unit for exoprosthetic fittings of the upper limbs; it measures electromyographic signals and assigns them to the movements of the prosthesis [104,105]. Through calibration using the Myo Plus App, the control unit assigns muscle signals to various types of movement of the prosthesis.

COMPLETE CONTROL System Gen2 – The COMPLETE CONTROL System Gen2 is used as the control unit for external prosthetic fittings of the upper limbs [106]. It employs pattern recognition technology to acquire muscle signals for the control of the upper extremity prostheses.

Sense System with IBT Electrodes – The Sense System is a surface electromyography electrode system designed to enhance control of upper limb prosthetic devices [107].

Seizure

Embrace – The Embrace is a device that provides an adjunct to seizure monitoring in home or health care facilities [103,108]. The device senses electrodermal activity and motion data and detects patterns potentially associated with generalized tonic clonic seizures. When a seizure event is identified, a paired wireless device will initiate an alert to a designated caregiver. The data is stored for subsequent review by the clinician.

Persyst 14 EEG Review And Analysis Software – Persyst 14 EEG Review and Analysis Software assists in the review of ambulatory electroencephalography (EEG) data [109-111].

OBSTETRICS AND GYNECOLOGY

In vitro fertilization

KIDScore D3 – The KIDScore D3 tool predicts of likelihood of embryos' development by scoring them according to their statistical viability [112]. If multiple embryos appear suitable for transfer or freezing, the tool provides additional information to assist in the embryo selection for either transfer, freezing, or continued development.

OPHTHALMOLOGY

Diabetic retinopathy

Idx-DR v2.3 – Idx-DR is used with Topcon NW400 to automatically detect (more than mild) diabetic retinopathy in the eyes of adults with diabetes who have not been previously diagnosed with diabetic retinopathy [94,113-118].

EyeArt – EyeArt automatically detects (more than mild) diabetic retinopathy as well as more severe diabetic retinopathy in eyes of adults with diabetes who have not been previously diagnosed with diabetic retinopathy [119-121].

Other diseases in the retina and ocular surface

CLARUS – The CLARUS model 700 is an active, software imaging device that captures, displays, stores, and annotates images of the eye to assist in the diagnosis and monitoring of diseases affecting the ocular surface, retina, and visible adnexa [122,123].

IRIS Intelligent Retinal Imaging System – The IRIS software is a service application that allows clinicians to scan a patient's retina with a fundus camera, upload the images to a website and provide an interpretation of the scans [124,125].

Visual tracking impairment

RightEye Vision System – The RightEye Vision System views, records, and analyzes eye movements in patients who may have impairments of visual tracking [126,127].

PEDIATRICS

Autism spectrum disorder

EarliPoint System – The EarliPoint System is indicated for use in specialized developmental disabilities centers as a tool to aid clinicians in the diagnosis and assessment of autism spectrum disorder (ASD) in patients ages 16 months through 30 months [128,129]. EarliPoint Device with eye-tracking capability captures the patient visual response to social information provided in the form of a series of age appropriate videos.

Cognoa Autism Spectrum Disorder Diagnosis Aid – The Cognoa ASD Diagnosis Aid uses a machine-learning algorithm that integrates information from caregivers and clinicians to assist in diagnosing ASD [130]. It comprises of both software applications and hardware platforms. Users input data via a mobile app, a video analyst portal, and/or a health care provider portal.

PULMONOLOGY AND SLEEP MEDICINE

Spirometry

Air Next – Air Next is a hand-held spirometer that measures parameters such as the forced expiratory volume in 1 sec and the forced vital capacity for use in assessing and monitoring disease that affect lung function (eg, cystic fibrosis, asthma, chronic obstructive pulmonary disease) [131-136].

Sleep

Compumedics Sleep Monitoring System – The Compumedics Sleep Monitoring System assists in diagnosing of sleep disorders [137] by integrating the recording of electroencephalography, electrocardiograms, respiratory and body position sensors, and oximeters.

MATRx Plus – MATRx Plus assists in the assessment of sleep disordered breathing in the home setting [138,139] by recording respiratory nasal flow, snoring, blood oxygen saturation, pulse, respiratory effort and body position during sleep.

SnoreSounds – SnoreSounds is a smartphone app to diagnose obstructive sleep apnea [140]. The software analyzes snoring quantitatively and qualitatively.

EnsoSleep – EnsoSleep assesses sleep parameters in order to identify respiratory related sleep disorders [141]. Along with the stage of sleep, the devices detects arousals, leg movements, and breathing events such as obstructive apneas, central sleep apneas, and hypopneas.

SURGERY

Wound healing

SpectralMD DeepView Wound Imaging System 2.0 – The SpectralMD DeepView Wound Imaging System provides images of blood flow in the microcirculation and provides an assessment of perfusion of both healthy and injured skin (eg, skin flaps, chronic wounds, decubitus ulcers, diabetic ulcers, and burns) [142].

MIMOSA Imager – The MIMOSA Imager is used in the ambulatory care setting to estimate the spatial distribution of percent oxygen saturation in tissue during the examination of patients with suspected circulatory compromise [143].

Margin evaluation

OTIS 2.1 Optical Coherence Tomography System, ThiA Optical Coherence Tomography System – The Perimeter OTIS 2.1 images excised tissue using optical coherence tomography, in order to visualize intraoperative margins [144].

Laparoscopy

TransEnterix Senhance Surgical System – The Senhance Surgical System is used in a variety of laparoscopic surgeries to assist in controlling laparoscopic instruments, both for visualization as well as for endoscopic manipulations such as grasping, cutting, dissecting, electrocautery, and suturing [145-148].

Estimation of blood loss

Triton System – The Triton System is a software application used on an Apple iPad that captures images of used surgical sponges in order to estimate blood loss and to assist operating room personnel in the management of surgical sponges after surgical use [149,150].

Intraoperative monitoring

NuVasive Pulse System – The Pulse NVM5 provides intraoperative neurophysiologic monitoring during neck dissections, spinal and thoracic surgeries, and surgeries of the upper and lower extremities [151].

Stereotactic image guidance

7D Surgical System Cranial Biopsy and Ventricular Catheter Placement Application – The 7D Surgical System is a stereotactic image guidance system to assist in spatial positioning of neurosurgical instruments [152,153].

SUMMARY

Inclusion of a given device in this topic does not indicate UpToDate endorsement of its use.

Medical devices are more frequently relying upon software incorporating artificial intelligence (AI).

The list includes devices enabled by AI/machine learning that have been approved by the US Food and Drug Administration (FDA) approval.

Please refer to UpToDate content on relevant clinical issues for information on the UpToDate approach to diagnosis, monitoring, and management.

  1. Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices. US Food and Drug Administration. Available at: https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices (Accessed on April 05, 2023).
  2. Medical AI Evaluation. Available at: https://ericwu09.github.io/medical-ai-evaluation/ (Accessed on April 05, 2023).
  3. DeepRhythmAI. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K210822 (Accessed on March 22, 2023).
  4. Study Watch with Irregular Pulse Monitor (Home), Study Watch with Irregular Pulse Monitor. 510(k) Premarket Notification. US Food and Drug Administration. Available at: www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K213357 (Accessed on March 22, 2023).
  5. Study Watch. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K182456 (Accessed on April 05, 2023).
  6. ZEUS System (Zio Watch). 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K213409 (Accessed on March 22, 2023).
  7. Atrial Fibrillation History Feature. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K213971 (Accessed on March 22, 2023).
  8. Khushhal A, Nichols S, Evans W, et al. Validity and Reliability of the Apple Watch for Measuring Heart Rate During Exercise. Sports Med Int Open 2017; 1:E206.
  9. IRNF App. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K212516 (Accessed on March 22, 2023).
  10. Dhruva SS, Shah ND, Vemulapalli S, et al. Heart Watch Study: protocol for a pragmatic randomised controlled trial. BMJ Open 2021; 11:e054550.
  11. AliveCor QT Service. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K212662 (Accessed on March 22, 2023).
  12. Koltowski L, Balsam P, Glowczynska R, et al. Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center. Cardiol J 2021; 28:543.
  13. IM007. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K210543 (Accessed on March 22, 2023).
  14. LINQ II Insertable Cardiac Monitor, Zelda AI ECG Classification System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K210484 (Accessed on April 04, 2023).
  15. Nölker G, Mayer J, Boldt LH, et al. Performance of an Implantable Cardiac Monitor to Detect Atrial Fibrillation: Results of the DETECT AF Study. J Cardiovasc Electrophysiol 2016; 27:1403.
  16. Zio ECG Utilization Software (ZEUS) System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K202527 (Accessed on April 04, 2023).
  17. Gladstone DJ, Wachter R, Schmalstieg-Bahr K, et al. Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial. JAMA Cardiol 2021; 6:558.
  18. Zio AT ECG Monitoring System, ZEUS System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K181502 (Accessed on April 05, 2023).
  19. Steinhubl SR, Waalen J, Sanyal A, et al. Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening-mHealth Screening to Prevent Strokes (mSToPS). PLoS One 2021; 16:e0258276.
  20. VX1. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K201298 (Accessed on April 04, 2023).
  21. Seitz J, Durdez TM, Albenque JP, et al. Artificial intelligence software standardizes electrogram-based ablation outcome for persistent atrial fibrillation. J Cardiovasc Electrophysiol 2022; 33:2250.
  22. RX-1 Rhythm Express Remote Cardiac Monitoring System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K200833 (Accessed on April 04, 2023).
  23. BodyGuardian Remote Monitoring System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K192732 (Accessed on April 04, 2023).
  24. AI-ECG Tracker. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K200036 (Accessed on April 04, 2023).
  25. AI-ECG Platform. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K180432 (Accessed on April 05, 2023).
  26. Eko Analysis Software. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K192004 (Accessed on April 04, 2023).
  27. physIQ Heart Rhythm and Respiratory Module. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K183322 (Accessed on April 04, 2023).
  28. Stehlik J, Schmalfuss C, Bozkurt B, et al. Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study. Circ Heart Fail 2020; 13:e006513.
  29. Loop System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K181352 (Accessed on April 04, 2023).
  30. Fan KG, Mandel J, Agnihotri P, Tai-Seale M. Remote Patient Monitoring Technologies for Predicting Chronic Obstructive Pulmonary Disease Exacerbations: Review and Comparison. JMIR Mhealth Uhealth 2020; 8:e16147.
  31. KardiaAI. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K181823 (Accessed on April 05, 2023).
  32. Mayfield JJ, Chatterjee NA, Noseworthy PA, et al. Implementation of a fully remote randomized clinical trial with cardiac monitoring. Commun Med (Lond) 2021; 1:62.
  33. RhythmAnalytics. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K182344 (Accessed on April 05, 2023).
  34. RX-1 Rhythm Express Remote Cardiac Monitoring System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K183704 (Accessed on April 05, 2023).
  35. Cardio-TriTest v6.5. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K182790 (Accessed on April 05, 2023).
  36. FibriCheck. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf17/K173872.pdf (Accessed on April 05, 2023).
  37. Rooti Rx ECG Event Recorder, Rooti Link APP Software. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K163694 (Accessed on April 05, 2023).
  38. Rooti Rx ECG Event Recorder, Rooti Link APP Software. FDA report. Available at: https://fda.report/PMN/K163694 (Accessed on April 05, 2023).
  39. Peerbridge Cor(TM) System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K171936 (Accessed on April 05, 2023).
  40. CardioLogs ECG Analysis Platform. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K170568 (Accessed on April 05, 2023).
  41. Fiorina L, Maupain C, Gardella C, et al. Evaluation of an Ambulatory ECG Analysis Platform Using Deep Neural Networks in Routine Clinical Practice. J Am Heart Assoc 2022; 11:e026196.
  42. Reveal LINQ. 510(k) Summary. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf13/k132649.pdf (Accessed on April 05, 2023).
  43. Sanders P, Pürerfellner H, Pokushalov E, et al. Performance of a new atrial fibrillation detection algorithm in a miniaturized insertable cardiac monitor: Results from the Reveal LINQ Usability Study. Heart Rhythm 2016; 13:1425.
  44. Pürerfellner H, Sanders P, Pokushalov E, et al. Miniaturized Reveal LINQ insertable cardiac monitoring system: First-in-human experience. Heart Rhythm 2015; 12:1113.
  45. FEops HEARTguide. Device Classification Under Section 513(f)(2)(De Novo). US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN200030 (Accessed on March 31, 2023).
  46. Halim J, Brouwer J, Lycke M, et al. Transcatheter aortic valve replacement: impact of pre-procedural FEops HEARTguide assessment on device size selection in borderline annulus size cases. Neth Heart J 2021; 29:654.
  47. Garot P, Iriart X, Aminian A, et al. Value of FEops HEARTguide patient-specific computational simulations in the planning of left atrial appendage closure with the Amplatzer Amulet closure device: rationale and design of the PREDICT-LAA study. Open Heart 2020; 7.
  48. Ranard LS, Vahl TP, Sommer R, et al. FEops HEARTguide Patient-Specific Computational Simulations for WATCHMAN FLX Left Atrial Appendage Closure: A Retrospective Study. JACC Adv 2022; 1.
  49. Sadeh B, Merdler I, Sadon S, et al. A novel contact-free atrial fibrillation monitor: a pilot study. Eur Heart J Digit Health 2022; 3:105.
  50. Gili Pro BioSensor (Also Known As "Gili BioSensor System"). Device Classification Under Section 513(f)(2)(De Novo). US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN200038 (Accessed on April 04, 2023).
  51. Oxehealth Vital Signs. Device Classification Under Section 513(f)(2)(De Novo). US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN200019 (Accessed on April 04, 2023).
  52. Jorge J, Villarroel M, Tomlinson H, et al. Non-contact physiological monitoring of post-operative patients in the intensive care unit. NPJ Digit Med 2022; 5:4.
  53. Analytic For Hemodynamic Instability (AHI). Device Classification Under Section 513(f)(2)(De Novo). US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN200022 (Accessed on April 04, 2023).
  54. Schmitzberger FF, Hall AE, Hughes ME, et al. Detection of Hemodynamic Status Using an Analytic Based on an Electrocardiogram Lead Waveform. Crit Care Explor 2022; 4:e0693.
  55. CLEWICU System (ClewICUServer and ClewICUnitor). 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K200717 (Accessed on April 04, 2023).
  56. Gaur S, Achenbach S, Leipsic J, et al. Rationale and design of the HeartFlowNXT (HeartFlow analysis of coronary blood flow using CT angiography: NeXt sTeps) study. J Cardiovasc Comput Tomogr 2013; 7:279.
  57. Nørgaard BL, Leipsic J, Gaur S, et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). J Am Coll Cardiol 2014; 63:1145.
  58. Nørgaard BL, Gaur S, Fairbairn TA, et al. Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis. Heart 2022; 108:194.
  59. PeraMobile and PeraWatch. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K183370 (Accessed on April 04, 2023).
  60. PeraServer and PeraTrend. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K172959 (Accessed on April 05, 2023).
  61. Wong CK, Ho DTY, Tam AR, et al. Artificial intelligence mobile health platform for early detection of COVID-19 in quarantine subjects using a wearable biosensor: protocol for a randomised controlled trial. BMJ Open 2020; 10:e038555.
  62. Biovitals Analytics Engine. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K183282 (Accessed on April 04, 2023).
  63. Acumen Hypotension Prediction Index – EV1000 Clinical Platform, Acumen Hypotension Prediction Index – HemoSphere Advanced Monitoring Platform, Acumen Hypotension Prediction Index – HemoSphere Advanced Monitoring Platform - Pressure. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K183646 (Accessed on April 04, 2023).
  64. Acumen Hypotension Prediction Index (HPI) Feature Software. Device Classification Under Section 513(f)(2)(De Novo). US Food and Drug Administration. Available at: www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN160044 (Accessed on April 05, 2023).
  65. WAVE Clinical Platform. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K171056 (Accessed on April 05, 2023).
  66. Tyto Stethoscope. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K160401 (Accessed on April 05, 2023).
  67. McDaniel NL, Novicoff W, Gunnell B, Cattell Gordon D. Comparison of a Novel Handheld Telehealth Device with Stand-Alone Examination Tools in a Clinic Setting. Telemed J E Health 2019; 25:1225.
  68. Personalized Physiology Analytics Engine software. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K142512 (Accessed on April 05, 2023).
  69. VISENSIA. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K081140 (Accessed on April 05, 2023).
  70. Hravnak M, Devita MA, Clontz A, et al. Cardiorespiratory instability before and after implementing an integrated monitoring system. Crit Care Med 2011; 39:65.
  71. Eko Murmur Analysis Software (EMAS). 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K213794 (Accessed on March 22, 2023).
  72. eMurmur Heart AI. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K220766 (Accessed on March 22, 2023).
  73. Lai LS, Redington AN, Reinisch AJ, et al. Computerized Automatic Diagnosis of Innocent and Pathologic Murmurs in Pediatrics: A Pilot Study. Congenit Heart Dis 2016; 11:386.
  74. eMurmur ID. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K181988 (Accessed on April 04, 2023).
  75. Stethee Pro 1, Stethee Pro Software System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K193631 (Accessed on April 04, 2023).
  76. Steth IO. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K160016 (Accessed on April 05, 2023).
  77. DEEPVESSEL FFR. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K213657 (Accessed on March 22, 2023).
  78. Wang ZQ, Zhou YJ, Zhao YX, et al. Diagnostic accuracy of a deep learning approach to calculate FFR from coronary CT angiography. J Geriatr Cardiol 2019; 16:42.
  79. FFRangio. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K192442 (Accessed on April 04, 2023).
  80. Fearon WF, Achenbach S, Engstrom T, et al. Accuracy of Fractional Flow Reserve Derived From Coronary Angiography. Circulation 2019; 139:477.
  81. FFRangio System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K182149 (Accessed on April 05, 2023).
  82. HeartFlow FFRct Analysis. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K190925 (Accessed on April 04, 2023).
  83. FFRct. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K161772 (Accessed on April 05, 2023).
  84. SOZO. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K172507 (Accessed on April 05, 2023).
  85. Accardi AJ, Matsubara BS, Gaw RL, et al. Clinical Utility of Fluid Volume Assessment in Heart Failure Patients Using Bioimpedance Spectroscopy. Front Cardiovasc Med 2021; 8:636718.
  86. DreaMed Advisor Pro. Device Classification Under Section 513(f)(2)(De Novo). US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN170043 (Accessed on April 05, 2023).
  87. One Drop Blood Glucose Monitoring System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K161834 (Accessed on April 05, 2023).
  88. Dario Blood Glucose Monitoring System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K150817 (Accessed on April 05, 2023).
  89. WellDoc BlueStar. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K190013 (Accessed on April 05, 2023).
  90. Agarwal P, Mukerji G, Desveaux L, et al. Mobile App for Improved Self-Management of Type 2 Diabetes: Multicenter Pragmatic Randomized Controlled Trial. JMIR Mhealth Uhealth 2019; 7:e10321.
  91. d-Nav System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K181916 (Accessed on April 05, 2023).
  92. Green W, Taylor M. Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers. Diabetes Ther 2016; 7:511.
  93. EndoTool SubQ. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K142918 (Accessed on April 05, 2023).
  94. IDx-DR v2.3. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K213037 (Accessed on April 05, 2023).
  95. GI Genius. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K211951 (Accessed on April 05, 2023).
  96. NvisionVLE Imaging System, NvisionVLE Optical Probe, NvisionVLE Inflation System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K182616 (Accessed on April 05, 2023).
  97. 23andMe Personal Genome Service (PGS) Genetic Health Risk Test For Hereditary Thrombophilia. Device Classification Under Section 513(f)(2)(De Novo). US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN160026 (Accessed on April 05, 2023).
  98. Minuteful - kidney test. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K210069 (Accessed on April 05, 2023).
  99. ACR LAB Urine Analysis Test System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K182384 (Accessed on April 05, 2023).
  100. DIP/U.S. Urine Analysis Test System. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf17/K173327.pdf (Accessed on April 05, 2023).
  101. BrainScope TBI. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K190815 (Accessed on April 05, 2023).
  102. EyeBOX. Device Classification Under Section 513(f)(2)(De Novo). 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/denovo.cfm?ID=DEN170091 (Accessed on April 05, 2023).
  103. Samadani U, Spinner RJ, Dynkowski G, et al. Eye tracking for classification of concussion in adults and pediatrics. Front Neurol 2022; 13:1039955.
  104. Myo Plus. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K191179 (Accessed on April 05, 2023).
  105. Franzke AW, Kristoffersen MB, Bongers RM, et al. Users' and therapists' perceptions of myoelectric multi-function upper limb prostheses with conventional and pattern recognition control. PLoS One 2019; 14:e0220899.
  106. COMPLETE CONTROL System Gen2. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K191083 (Accessed on April 05, 2023).
  107. Sense System with IBT Electrodes. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K182112 (Accessed on April 05, 2023).
  108. Embrace. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K181861 (Accessed on April 05, 2023).
  109. Persyst 14 EEG Review and Analysis Software. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K182181 (Accessed on April 05, 2023).
  110. Ganguly TM, Ellis CA, Tu D, et al. Seizure Detection in Continuous Inpatient EEG: A Comparison of Human vs Automated Review. Neurology 2022; 98:e2224.
  111. Scheuer ML, Wilson SB, Antony A, et al. Seizure Detection: Interreader Agreement and Detection Algorithm Assessments Using a Large Dataset. J Clin Neurophysiol 2021; 38:439.
  112. KIDScore D3. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K182798 (Accessed on April 05, 2023).
  113. IDx-DR. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K203629 (Accessed on April 05, 2023).
  114. IDx-DR. Device Classification Under Section 513(f)(2)(De Novo). US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?ID=DEN180001 (Accessed on April 05, 2023).
  115. Grzybowski A, Brona P. Analysis and Comparison of Two Artificial Intelligence Diabetic Retinopathy Screening Algorithms in a Pilot Study: IDx-DR and Retinalyze. J Clin Med 2021; 10.
  116. Abràmoff MD, Lavin PT, Birch M, et al. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med 2018; 1:39.
  117. Abramoff MD, Mortensen Z, Tava C. Commentary: Diagnosing Diabetic Retinopathy With Artificial Intelligence: What Information Should Be Included to Ensure Ethical Informed Consent? Front Med (Lausanne) 2021; 8:765936.
  118. Shah A, Clarida W, Amelon R, et al. Validation of Automated Screening for Referable Diabetic Retinopathy With an Autonomous Diagnostic Artificial Intelligence System in a Spanish Population. J Diabetes Sci Technol 2021; 15:655.
  119. EyeArt. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K200667 (Accessed on April 05, 2023).
  120. Ipp E, Liljenquist D, Bode B, et al. Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy. JAMA Netw Open 2021; 4:e2134254.
  121. Bhaskaranand M, Ramachandra C, Bhat S, et al. The Value of Automated Diabetic Retinopathy Screening with the EyeArt System: A Study of More Than 100,000 Consecutive Encounters from People with Diabetes. Diabetes Technol Ther 2019; 21:635.
  122. CLARUS. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K191194 (Accessed on April 05, 2023).
  123. Chen A, Dang S, Chung MM, et al. Quantitative Comparison of Fundus Images by 2 Ultra-Widefield Fundus Cameras. Ophthalmol Retina 2021; 5:450.
  124. IRIS INTELLIGENT RETINAL IMAGING SYSTEM. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K141922 (Accessed on April 05, 2023).
  125. Naik S, Wykoff CC, Ou WC, et al. Identification of factors to increase efficacy of telemedicine screening for diabetic retinopathy in endocrinology practices using the Intelligent Retinal Imaging System (IRIS) platform. Diabetes Res Clin Pract 2018; 140:265.
  126. RightEye Vision System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K181771 (Accessed on April 05, 2023).
  127. Murray NP, Hunfalvay M, Bolte T. The Reliability, Validity, and Normative Data of Interpupillary Distance and Pupil Diameter Using Eye-Tracking Technology. Transl Vis Sci Technol 2017; 6:2.
  128. Solutions. EarliTec Diagnostics Inc. Available at: https://www.earlitecdx.com/solutions/ (Accessed on March 22, 2023).
  129. Klaiman C, White S, Richardson S, et al. Expert Clinician Certainty in Diagnosing Autism Spectrum Disorder in 16-30-Month-Olds: A Multi-site Trial Secondary Analysis. J Autism Dev Disord 2022; :1.
  130. Cognoa ASD Diagnosis Aid. Device Classification Under Section 513(f)(2)(De Novo). US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN200069 (Accessed on April 05, 2023).
  131. Air Next. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K183089 (Accessed on September 21, 2022).
  132. Validation study of the portable Air Next spirometer: preliminary results. European Respiratory Journal 2019. Available at: https://erj.ersjournals.com/content/54/suppl_63/PA2642 (Accessed on September 21, 2022).
  133. Exarchos KP, Gogali A, Sioutkou A, et al. Validation of the portable Bluetooth® Air Next spirometer in patients with different respiratory diseases. Respir Res 2020; 21:79.
  134. Validation study of the portable Air Next spirometer: preliminary results. e-learning resources. Available at: https://www.ers-education.org/lr/show-details/?idP=236417 (Accessed on September 23, 2022).
  135. Kruizinga MD, Essers E, Stuurman FE, et al. Technical validity and usability of a novel smartphone-connected spirometry device for pediatric patients with asthma and cystic fibrosis. Pediatr Pulmonol 2020; 55:2463.
  136. Ramos Hernández C, Núñez Fernández M, Pallares Sanmartín A, et al. Validation of the portable Air-Smart Spirometer. PLoS One 2018; 13:e0192789.
  137. Compumedics Sleep Monitoring System. 510(k) Summary. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf/K955841.pdf (Accessed on April 05, 2023).
  138. MATRx plus. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K163665 (Accessed on September 21, 2022).
  139. Mosca EV, Bruehlmann S, Zouboules SM, et al. In-home mandibular repositioning during sleep using MATRx plus predicts outcome and efficacious positioning for oral appliance treatment of obstructive sleep apnea. J Clin Sleep Med 2022; 18:911.
  140. SnoreSounds. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K150102 (Accessed on September 21, 2022).
  141. EnsoSleep. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K210034 (Accessed on April 05, 2023).
  142. SPECTRALMD DEEPVIEW WOUND IMAGING SYSTEM 2.0. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K163339 (Accessed on April 05, 2023).
  143. MIMOSA Imager. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K190334 (Accessed on April 05, 2023).
  144. OTIS 2.1 Optical Coherence Tomography System, THiA Optical Coherence Tomography System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K203578 (Accessed on April 05, 2023).
  145. TransEnterix Senhance Surgical System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K180163 (Accessed on April 05, 2023).
  146. Panico G, Campagna G, Vacca L, et al. The Senhance ® assisted laparoscopy in urogynaecology: case report of sacral colpopexy with subtotal hysterectomy with bilateral salpingo-oophorectomy for pelvic organ prolapse *: * Video Article, to see the video use this link: https://qrco.de/bbdi3G. Facts Views Vis Obgyn 2020; 12:245.
  147. Khitaryan AG, Matveev NL, Veliev KS, et al. [The first clinical experience of using the new Senhance remote-controlled robotic system in general surgery in Russia]. Khirurgiia (Mosk) 2022; :5.
  148. Lin CC, Huang SC, Lin HH, et al. An early experience with the Senhance surgical robotic system in colorectal surgery: a single-institute study. Int J Med Robot 2021; 17:e2206.
  149. Triton System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K160338 (Accessed on April 05, 2023).
  150. Holmes AA, Konig G, Ting V, et al. Clinical evaluation of a novel system for monitoring surgical hemoglobin loss. Anesth Analg 2014; 119:588.
  151. NuVasive Pulse System. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K180038 (Accessed on April 05, 2023).
  152. 7D Surgical System Cranial Biopsy and Ventricular Catheter Placement Application. 510(k) Premarket Notification. US Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K192945 (Accessed on April 05, 2023).
  153. Kalfas IH. Machine Vision Navigation in Spine Surgery. Front Surg 2021; 8:640554.
Topic 139675 Version 1.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟